February 10, 2026
CAPTIVA’s Low-Dose Rivaroxaban Arm Halted
The National Institutes of Health (NIH) has stopped an investigational treatment arm of the study, following a regular review by the Data Safety and Monitoring Board.
November 24, 2025
CAPTIVA Site in South Carolina Enrolls the 842nd Subject
The Medical University of South Carolina’s enrollment represents 50% of the total enrollment goal. A huge milestone for the study!
December 10, 2024
CAPTIVA’s 570th Enrollment Reaches Landmark Number
CAPTIVA has recruited more subjects than any other clinical trial dedicated to symptomatic intracranial arterial stenosis.
May 24, 2024
CAPTIVA Site in Minnesota Enrolls the 421st Subject
M Health Fairview University of Minnesota Medical Center’s enrollment represents 25% of the total enrollment goal.
February 10, 2022
CAPTIVA at the American Heart Association
Dr. Brian Hoh presents the CAPTIVA trial at the American Heart Association International Stroke Conference.
September 1, 2021
CAPTIVA at the Medical University of South Carolina
CAPTIVA trial will test ways to prevent a second stroke in patients with a narrowed brain artery.
August 31, 2021
CAPTIVA Receives National Institutes of Health Grant
UF Health neurosurgeon awarded $38 million grant to lead national stroke prevention trial.
